IL212590A0 - New compounds 578 - Google Patents

New compounds 578

Info

Publication number: IL212590A0
Authority: IL; Israel
Prior art keywords: new compounds; compounds; new
Prior art date: 2008-11-14

Application number

IL212590A

Other languages

English (en)

Original Assignee

Astrazeneca Ab

Swahn Britt Marie

Soderman Peter

Rotticci Didier

Kolmodin Karin

Lindstrom Johan

Holenz Jorg

Karlstrom Sofia

Von Berg Stefan

Rakos Laszlo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-11-14

Filing date

2011-04-28

Publication date

2011-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42170158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL212590(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-04-28 Application filed by Astrazeneca Ab, Swahn Britt Marie, Soderman Peter, Rotticci Didier, Kolmodin Karin, Lindstrom Johan, Holenz Jorg, Karlstrom Sofia, Von Berg Stefan, Rakos Laszlo filed Critical Astrazeneca Ab

2011-07-31 Publication of IL212590A0 publication Critical patent/IL212590A0/en

Links

150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL212590A 2008-11-14 2011-04-28 New compounds 578 IL212590A0 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US11463408P	2008-11-14	2008-11-14
US13976708P	2008-12-22	2008-12-22
US22165309P	2009-06-30	2009-06-30
PCT/SE2009/051295 WO2010056196A1 (en)	2008-11-14	2009-11-13	New compounds 578

Publications (1)

Publication Number	Publication Date
IL212590A0 true IL212590A0 (en)	2011-07-31

Family

ID=42170158

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL212590A IL212590A0 (en)	2008-11-14	2011-04-28	New compounds 578

Country Status (24)

Country	Link
US (2)	US8030500B2 (2)
EP (1)	EP2367814A4 (2)
JP (1)	JP2012508734A (2)
KR (1)	KR20110091540A (2)
CN (1)	CN102282140A (2)
AR (1)	AR074341A1 (2)
AU (1)	AU2009314664A1 (2)
BR (1)	BRPI0921879A2 (2)
CA (1)	CA2743938A1 (2)
CL (1)	CL2011001098A1 (2)
CO (1)	CO6362004A2 (2)
CR (1)	CR20110255A (2)
CU (1)	CU20110106A7 (2)
DO (1)	DOP2011000138A (2)
EA (1)	EA201190020A1 (2)
EC (1)	ECSP11011051A (2)
IL (1)	IL212590A0 (2)
MX (1)	MX2011004918A (2)
NI (1)	NI201100099A (2)
PE (1)	PE20110875A1 (2)
TW (1)	TW201020244A (2)
UY (1)	UY32241A (2)
WO (1)	WO2010056196A1 (2)
ZA (1)	ZA201104396B (2)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2628074C (en)	2005-10-25	2014-01-14	Shionogi & Co., Ltd.	Aminodihydrothiazine derivative
TW200815349A (en) *	2006-06-22	2008-04-01	Astrazeneca Ab	New compounds
US8653067B2 (en)	2007-04-24	2014-02-18	Shionogi & Co., Ltd.	Pharmaceutical composition for treating Alzheimer's disease
JP5383484B2 (ja)	2007-04-24	2014-01-08	塩野義製薬株式会社	環式基で置換されたアミノジヒドロチアジン誘導体
KR101324426B1 (ko)	2008-06-13	2013-10-31	시오노기세야쿠 가부시키가이샤	β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
CN102186841A (zh)	2008-10-22	2011-09-14	盐野义制药株式会社	具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
UA108363C2 (uk)	2009-10-08	2015-04-27		Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
WO2011044187A1 (en)	2009-10-08	2011-04-14	Schering Corporation	Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
MX2012006491A (es)	2009-12-11	2012-07-03	Shionogi & Co	Derivados de oxazina.
US20110281894A1 (en) *	2010-05-12	2011-11-17	Astrazeneca Ab	Hemifumarate salt
US8921363B2 (en)	2010-08-05	2014-12-30	Amgen Inc.	Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors
EP2634188A4 (en)	2010-10-29	2014-05-07	Shionogi & Co	FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
JP5816630B2 (ja)	2010-10-29	2015-11-18	塩野義製薬株式会社	ナフチリジン誘導体
US20120165346A1 (en) *	2010-12-22	2012-06-28	Astrazeneca Ab	Compounds and their use as BACE inhibitors
US8883779B2 (en)	2011-04-26	2014-11-11	Shinogi & Co., Ltd.	Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them
EP2912035A4 (en)	2012-10-24	2016-06-15	Shionogi & Co	DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
EP3353844B1 (en)	2015-03-27	2022-05-11	Mason K. Harrup	All-inorganic solvents for electrolytes
CN105272884B (zh) *	2015-11-02	2017-05-24	浙江大学	一种邻氰基二苯甲酮衍生物的制备方法
US10707531B1 (en)	2016-09-27	2020-07-07	New Dominion Enterprises Inc.	All-inorganic solvents for electrolytes

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4605642A (en) *	1984-02-23	1986-08-12	The Salk Institute For Biological Studies	CRF antagonists
US5063245A (en) *	1990-03-28	1991-11-05	Nova Pharmaceutical Corporation	Corticotropin-releasing factor antagonism compounds
AU702293B2 (en) *	1993-10-27	1999-02-18	Athena Neurosciences, Inc.	Transgenic animals harboring APP allele having Swedish mutation
US5877399A (en) *	1994-01-27	1999-03-02	Johns Hopkins University	Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
DE4419849A1 (de)	1994-06-07	1995-12-14	Hoechst Ag	Isoindolinpigmente
DK0765327T3 (da)	1994-06-16	1999-11-29	Pfizer	Pyrazolo- og pyrrolopyridiner
DE19516804A1 (de)	1995-05-08	1996-11-14	Hoechst Ag	Isoindolinpigmente auf Basis von Aminochinoxalindionen
JPH11507538A (ja) *	1995-06-07	1999-07-06	アテナニューロサイエンシズインコーポレイティド	β−セクレターゼ、β−セクレターゼに対する抗体、及びβ−セクレターゼ阻害を検出するためのアッセイ
US6211235B1 (en) *	1996-11-22	2001-04-03	Elan Pharmaceuticals, Inc.	Compounds for inhibiting β-amyloid peptide release and/or its synthesis
GB9701684D0 (en)	1997-01-28	1997-03-19	Smithkline Beecham Plc	Novel compounds
US6245769B1 (en)	1997-09-02	2001-06-12	Dupont Pharmaceuticals Company	Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders
US5981168A (en) *	1998-05-15	1999-11-09	The University Of British Columbia	Method and composition for modulating amyloidosis
PL205294B1 (pl)	1998-09-24	2010-03-31	Upjohn Co	Izolowany lub oczyszczony polipeptyd, oczyszczony lub izolowany polinukleotyd, wektor, wektor ekspresyjny, komórka gospodarza, sposób wytwarzania polipeptydu, sposoby identyfikowania czynnika obniżającego, modulującego lub hamującego aktywność, zastosowanie takiego czynnika, izolowany kwas nukleinowy, obejmujący go wektor i ich zastosowanie, sposoby zmniejszania komórkowego wytwarzania beta amyloidu i zastosowanie antysensownego reagenta
US6245884B1 (en) *	1998-10-16	2001-06-12	Vivian Y. H. Hook	Secretases related to alzheimer's dementia
GB2364059B (en)	1999-02-10	2004-01-14	Elan Pharm Inc	Beta-Secretase enzyme compositions and methods
WO2000058479A1 (en)	1999-03-26	2000-10-05	Amgen Inc.	Beta secretase genes and polypeptides
JP2003502342A (ja)	1999-06-15	2003-01-21	エランファーマスーティカルズインコーポレイテッド	ベータ−セクレターゼのスタチン誘導テトラペプチド阻害剤
CA2374610A1 (en)	1999-06-28	2001-01-04	Jordan J. N. Tang	Catalytically active recombinant memapsin and methods of use thereof
WO2001023533A2 (en)	1999-09-23	2001-04-05	Pharmacia & Upjohn Company	Alzheimer's disease secretase, app substrates therefor, and uses therefor
GB9924957D0 (en)	1999-10-21	1999-12-22	Smithkline Beecham Plc	Novel treatment
US6846813B2 (en)	2000-06-30	2005-01-25	Pharmacia & Upjohn Company	Compounds to treat alzheimer's disease
JP2004502664A (ja)	2000-06-30	2004-01-29	イーラン　ファーマスーティカルズ、インコーポレイテッド	アルツハイマー病処置用化合物
PE20020276A1 (es)	2000-06-30	2002-04-06	Elan Pharm Inc	COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
AU2001281250A1 (en)	2000-08-11	2002-02-25	The Brigham And Women's Hospital, Inc.	(hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production
WO2002025276A1 (en)	2000-09-22	2002-03-28	Wyeth	Crystal structure of bace and uses thereof
US7592348B2 (en)	2003-12-15	2009-09-22	Schering Corporation	Heterocyclic aspartyl protease inhibitors
EP2335701B1 (en)	2003-12-15	2012-07-11	Schering Corporation	Heterocyclic aspartyl protease inhibitors
JP2007530696A (ja)	2004-03-30	2007-11-01	メルク　エンド　カムパニー　インコーポレーテッド	アスパラギン酸プロテアーゼ阻害剤として有用な２−アミノチアゾール化合物
JP2008502687A (ja)	2004-06-14	2008-01-31	タケダサンディエゴインコーポレイテッド	キナーゼ阻害剤
BRPI0512213A (pt) *	2004-06-16	2008-02-19	Wyeth Corp	método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
RU2006144075A (ru)	2004-06-16	2008-07-27	Вайет (Us)	ДИФЕНИЛИМИДАЗОПИРИМИДИН И -ИМИДАЗОЛАМИНЫ КАК ИНГИБИТОРЫ β-СЕКРЕТАЗЫ
TW200613272A (en) *	2004-08-13	2006-05-01	Astrazeneca Ab	Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
WO2006034419A2 (en)	2004-09-21	2006-03-30	Athersys, Inc.	Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof
JP2008516945A (ja)	2004-10-15	2008-05-22	アストラゼネカ・アクチエボラーグ	置換されたアミノ化合物およびそれらの使用
EP1802588A4 (en)	2004-10-15	2010-02-17	Astrazeneca Ab	SUBSTITUTED AMINOPYRIMIDONE AND APPLICATIONS THEREOF
US20080287399A1 (en)	2004-12-14	2008-11-20	Astrazeneca Ab	Substituted Aminopyridines and Uses Thereof
CA2593515A1 (en) *	2005-01-14	2006-07-20	Wyeth	Amino-imidazolones for the inhibition of beta-secretase
US20060223849A1 (en)	2005-03-14	2006-10-05	Mjalli Adnan M	Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
WO2006138265A2 (en) *	2005-06-14	2006-12-28	Schering Corporation	Heterocyclic aspartyl protease inhibitors, preparation and use thereof
KR20080025079A (ko) *	2005-06-14	2008-03-19	쉐링 코포레이션	아스파르틸 프로테아제 억제제
EP1896406A2 (en)	2005-06-14	2008-03-12	Shering Corporation	The preparation and use of compounds as protease inhibitors
PE20070135A1 (es)	2005-06-14	2007-03-09	Schering Corp	Compuestos heterociclicos como inhibidores de aspartil proteasas
AR053902A1 (es) *	2005-06-14	2007-05-23	Schering Corp	Inhibidores de aspartil proteasa heterociclicos macrociclicos
ATE489370T1 (de)	2005-06-14	2010-12-15	Schering Corp	Herstellung und verwendung von verbindungen als aspartylproteasehemmer
AU2006266167A1 (en) *	2005-06-30	2007-01-11	Wyeth	Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
TW200738683A (en) *	2005-06-30	2007-10-16	Wyeth Corp	Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
JP2009502786A (ja)	2005-07-18	2009-01-29	メルクエンドカムパニーインコーポレーテッド	アルツハイマー病を治療するためのスピロピペリジンβ−セクレターゼ阻害剤
US7601751B2 (en) *	2005-09-01	2009-10-13	Bristol-Myers Squibb Company	Indole acetic acid acyl guanidines as β-secretase inhibitors
CA2628074C (en) *	2005-10-25	2014-01-14	Shionogi & Co., Ltd.	Aminodihydrothiazine derivative
ATE478070T1 (de) *	2005-10-27	2010-09-15	Schering Corp	Heterozyklische aspartyl-proteasehemmer
JP2009513670A (ja) *	2005-10-31	2009-04-02	シェーリングコーポレイション	アスパルチルプロテアーゼインヒビター
JP2009515950A (ja)	2005-11-15	2009-04-16	アストラゼネカ・アクチエボラーグ	新規な２−アミノピリミジン誘導体およびその使用
EP1951680A4 (en)	2005-11-15	2011-08-10	Astrazeneca Ab	NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
TW200804290A (en)	2005-11-15	2008-01-16	Astrazeneca Ab	Compounds and uses thereof
CN101360721A (zh)	2005-11-15	2009-02-04	阿斯利康(瑞典)有限公司	新颖的2-氨基嘧啶酮衍生物或2-氨基吡啶酮衍生物及其用途
TW200734311A (en)	2005-11-21	2007-09-16	Astrazeneca Ab	New compounds
WO2007058601A1 (en)	2005-11-21	2007-05-24	Astrazeneca Ab	Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia
AR058381A1 (es)	2005-12-19	2008-01-30	Astrazeneca Ab	Compuestos derivados de 2-aminopiridin-4-onas y una composicion farmaceutica
CN101460480A (zh)	2006-04-05	2009-06-17	阿斯利康(瑞典)有限公司	2-氨基嘧啶-4-酮类化合物及其用于治疗或预防Aβ相关病理的用途
TW200808751A (en)	2006-04-13	2008-02-16	Astrazeneca Ab	New compounds
PE20080155A1 (es)	2006-06-12	2008-03-10	Schering Corp	Compuestos heterociclicos como inhibidores de aspartil-proteasa
TW200815447A (en)	2006-06-14	2008-04-01	Astrazeneca Ab	Novel compounds IV
TW200815443A (en)	2006-06-14	2008-04-01	Astrazeneca Ab	Novel compounds I
TW200808796A (en)	2006-06-14	2008-02-16	Astrazeneca Ab	New compounds III
TW200815449A (en)	2006-06-14	2008-04-01	Astrazeneca Ab	Novel compounds II
TW200815349A (en) *	2006-06-22	2008-04-01	Astrazeneca Ab	New compounds
WO2008063114A1 (en)	2006-11-20	2008-05-29	Astrazeneca Ab	Amino- imidazolones and their use as medicament for treating cognitive impairment alzheimer disease, neurodegeneration and dementia
TW200831484A (en)	2006-12-20	2008-08-01	Astrazeneca Ab	New compounds
TW200831091A (en)	2006-12-20	2008-08-01	Astrazeneca Ab	New compounds
WO2008076044A1 (en)	2006-12-20	2008-06-26	Astrazeneca Ab	Novel 2-amino-5, 5-diaryl-imidazol-4-ones
TW200902499A (en) *	2007-05-15	2009-01-16	Astrazeneca Ab	New compounds
TW200902503A (en)	2007-05-15	2009-01-16	Astrazeneca Ab	New compounds
WO2009005471A1 (en) *	2007-07-05	2009-01-08	Astrazeneca Ab	Aryl and heteroaryl substituted isoindole derivatives as bace inhibitors
WO2009005470A1 (en) *	2007-07-05	2009-01-08	Astrazeneca Ab	Aryl and heteroaryl substituted isoindole derivatives as bace inhibitors
WO2010056195A1 (en)	2008-11-14	2010-05-20	Astrazeneca Ab	New compounds 575
US20100125081A1 (en) *	2008-11-14	2010-05-20	Astrazeneca Ab	New compounds 574
EP2485920B1 (en)	2009-10-08	2016-04-27	Merck Sharp & Dohme Corp.	Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
EP2485590B1 (en)	2009-10-08	2015-01-07	Merck Sharp & Dohme Corp.	Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
WO2011044187A1 (en)	2009-10-08	2011-04-14	Schering Corporation	Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
UA108363C2 (uk)	2009-10-08	2015-04-27		Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування

2009
- 2009-11-12 TW TW098138485A patent/TW201020244A/zh unknown
- 2009-11-13 PE PE2011001034A patent/PE20110875A1/es not_active Application Discontinuation
- 2009-11-13 US US12/618,212 patent/US8030500B2/en not_active Expired - Fee Related
- 2009-11-13 WO PCT/SE2009/051295 patent/WO2010056196A1/en not_active Ceased
- 2009-11-13 CN CN2009801545281A patent/CN102282140A/zh active Pending
- 2009-11-13 JP JP2011536289A patent/JP2012508734A/ja active Pending
- 2009-11-13 UY UY0001032241A patent/UY32241A/es not_active Application Discontinuation
- 2009-11-13 AU AU2009314664A patent/AU2009314664A1/en not_active Abandoned
- 2009-11-13 EA EA201190020A patent/EA201190020A1/ru unknown
- 2009-11-13 AR ARP090104400A patent/AR074341A1/es unknown
- 2009-11-13 BR BRPI0921879A patent/BRPI0921879A2/pt not_active Application Discontinuation
- 2009-11-13 EP EP09826375A patent/EP2367814A4/en not_active Withdrawn
- 2009-11-13 MX MX2011004918A patent/MX2011004918A/es not_active Application Discontinuation
- 2009-11-13 CA CA2743938A patent/CA2743938A1/en not_active Abandoned
- 2009-11-13 KR KR1020117013516A patent/KR20110091540A/ko not_active Withdrawn
2011
- 2011-04-28 IL IL212590A patent/IL212590A0/en unknown
- 2011-04-28 CO CO11052264A patent/CO6362004A2/es not_active Application Discontinuation
- 2011-05-13 CL CL2011001098A patent/CL2011001098A1/es unknown
- 2011-05-13 DO DO2011000138A patent/DOP2011000138A/es unknown
- 2011-05-13 NI NI201100099A patent/NI201100099A/es unknown
- 2011-05-13 CU CU20110106A patent/CU20110106A7/es unknown
- 2011-05-13 EC EC2011011051A patent/ECSP11011051A/es unknown
- 2011-05-13 CR CR20110255A patent/CR20110255A/es unknown
- 2011-06-13 ZA ZA2011/04396A patent/ZA201104396B/en unknown
- 2011-09-06 US US13/225,707 patent/US20110319426A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW201020244A (en)	2010-06-01
BRPI0921879A2 (pt)	2018-10-16
CO6362004A2 (es)	2012-01-20
JP2012508734A (ja)	2012-04-12
EA201190020A1 (ru)	2012-02-28
EP2367814A1 (en)	2011-09-28
US20100125082A1 (en)	2010-05-20
US20110319426A1 (en)	2011-12-29
US8030500B2 (en)	2011-10-04
CA2743938A1 (en)	2010-05-20
DOP2011000138A (es)	2011-06-30
CR20110255A (es)	2011-07-04
EP2367814A4 (en)	2012-07-04
CN102282140A (zh)	2011-12-14
CL2011001098A1 (es)	2012-02-24
KR20110091540A (ko)	2011-08-11
NI201100099A (es)	2012-03-19
AU2009314664A1 (en)	2011-06-23
AR074341A1 (es)	2011-01-12
WO2010056196A1 (en)	2010-05-20
UY32241A (es)	2010-06-30
MX2011004918A (es)	2011-05-30
ZA201104396B (en)	2012-03-28
ECSP11011051A (es)	2011-06-30
PE20110875A1 (es)	2012-01-11
CU20110106A7 (es)	2012-01-31

Publication	Publication Date	Title
GB0713686D0 (en)	2007-08-22	New compounds 2
IL212590A0 (en)	2011-07-31	New compounds 578
IL208405A0 (en)	2010-12-30	Substituted pyrimidin-5-carboxamides 281
GB0720038D0 (en)	2007-11-21	New compounds
GB0720041D0 (en)	2007-11-21	New Compounds
GB0810902D0 (en)	2008-07-23	New compounds
IL205513A0 (en)	2010-12-30	Novel compounds 132
IL205873A0 (en)	2010-11-30	Novel compounds 010
GB0722769D0 (en)	2008-01-02	New compounds
GB0701273D0 (en)	2007-02-28	New compounds
IL210344A0 (en)	2011-03-31	New compounds
GB0808708D0 (en)	2008-06-18	New compounds 274
GB0900404D0 (en)	2009-02-11	New compounds 4
HU0700395D0 (en)	2007-07-30	New compounds
GB0808707D0 (en)	2008-06-18	New compounds 275
IL202281A0 (en)	2010-06-16	New compounds 892
GB0912946D0 (en)	2009-09-02	New compounds 5
GB0811099D0 (en)	2008-07-23	New combination 376
GB0808709D0 (en)	2008-06-18	New combination 295
GB0905087D0 (en)	2009-05-06	Cypardon 2
HU0800478D0 (en)	2008-09-29	New compounds
GB0723342D0 (en)	2008-01-09	Novel compounds 2
GB0813324D0 (en)	2008-08-27	New compounds 3
GB0803103D0 (en)	2008-03-26	Novel compounds 3
GB0811131D0 (en)	2008-07-23	Novel compounds 336